|
|||||
|
|
Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation? |
|
| Authors: | François Laliberté Dominic Pilon Monika K Raut Winnie W Nelson William H Olson Guillaume Germain |
| Institution: | 1. Groupe d’analyse Ltée, Montréal, QCCanada;2. Janssen Scientific Affairs, LLC Raritan, NJUSA |
| Abstract: | |
| Keywords: | Anticoagulant agents Atrial fibrillation Length of stay Rivaroxaban Warfarin |